In our study, the adjuvant anti-tumor effect of FJHQ as a new type late-stage autophagy inhibitor against NSCLC was explored. It was found that FJHQ can block autophagy by inhibiting the maturation of cathepsin in lysosomes and induce the accumulation of ROS in tumor cells. The gene discussed is CTSS; the disease is neoplasm.